Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Klein

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 6, 2018
The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the LiverHemant Shah, Marc Bilodeau, Kelly W Burak, et al.
BMC Infectious Diseases|February 15, 2017
A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, CanadaChristina Greenaway, Laurent Azoulay, Robert Allard, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 30, 2016
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentMark Hull, Stephen Shafran, Alex Wong, et al.
Journal of Clinical Immunology|May 15, 2014
High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccineKaren K Yam, Erica Gipson, Marina Klein, et al.
AIDS (London, England)|November 24, 2025
Gut microbiome and healthy aging in HIV: data from the correlates of healthy aging in geriatric HIV (CHANGE HIV) cohortEric Armstrong, Eugene Seo, Bryan Boyachuk, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
Plos One|May 19, 2022
Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIVElaina Kaufman, Tyler Williamson, Marie-Hélène Mayrand, et al.
Frontiers in Medicine|May 1, 2024
Non-AIDS-defining comorbidities impact health related quality of life among older adults living with HIVAlice Zhabokritsky, Marina Klein, Mona Loutfy, et al.
HIV Clinical Trials|February 7, 2012
High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adultsCurtis Cooper, Marina Klein, Sharon Walmsley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2023
CD4/CD8 Ratio Outcome According to the Class of the Third Active Drug in Antiretroviral Therapy Regimens: Results From the Quebec Human Immunodeficiency Virus Cohort StudyMohamed N'dongo Sangaré, Jean-Guy Baril, Alexandra de Pokomandy, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 6, 2018
The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the LiverHemant Shah, Marc Bilodeau, Kelly W Burak, et al.
BMC Infectious Diseases|February 15, 2017
A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, CanadaChristina Greenaway, Laurent Azoulay, Robert Allard, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 30, 2016
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentMark Hull, Stephen Shafran, Alex Wong, et al.
Journal of Clinical Immunology|May 15, 2014
High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccineKaren K Yam, Erica Gipson, Marina Klein, et al.
AIDS (London, England)|November 24, 2025
Gut microbiome and healthy aging in HIV: data from the correlates of healthy aging in geriatric HIV (CHANGE HIV) cohortEric Armstrong, Eugene Seo, Bryan Boyachuk, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
Plos One|May 19, 2022
Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIVElaina Kaufman, Tyler Williamson, Marie-Hélène Mayrand, et al.
Frontiers in Medicine|May 1, 2024
Non-AIDS-defining comorbidities impact health related quality of life among older adults living with HIVAlice Zhabokritsky, Marina Klein, Mona Loutfy, et al.
HIV Clinical Trials|February 7, 2012
High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adultsCurtis Cooper, Marina Klein, Sharon Walmsley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2023
CD4/CD8 Ratio Outcome According to the Class of the Third Active Drug in Antiretroviral Therapy Regimens: Results From the Quebec Human Immunodeficiency Virus Cohort StudyMohamed N'dongo Sangaré, Jean-Guy Baril, Alexandra de Pokomandy, et al.
Pageof 8